The following video is part of our "Motley Fool Conversations" series, in which, Eric Bleeker, senior technology editor, and James Early, advisor, discuss topics around the investing world.
In today's edition, James suggests that dividend-focused investors look toward Johnson & Johnson. While there's been a high degree of pessimism surrounding the company as it's faced product recalls and other product missteps, James says the company is essentially a "mutual fund for the health-care industry" and has been unfairly beaten down.
Please enable JavaScript to view this video.
If you're interested in Johnson & Johnson on your quest for great high-yielders, The Motley Fool has compiled a special free report outlining our 11 favorite, dependable dividend-paying stocks. It's called "Secure Your Future With 11 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost. Just click here to discover the winners we've picked.
